Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

43

Revenue 2017

Perjeta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Perjeta was produced by Roche.

NHS names drugs to be re-evaluated for Cancer Drugs Fund

NHS names drugs to be re-evaluated for Cancer Drugs Fund Kadcyla (trastuzumab emtansine). Breast cancer. Perjeta (pertuzumab). Breast cancer. Sanofi. Jevtana (cabazitaxel).

SMC fails to recommend Roche’s Perjeta

SMC fails to recommend Roche’s Perjeta Says drug is not a cost-effective option in breast cancer. The Scottish Medicines Consortium (SMC) has not recommended Roche's Perjeta for use in the treatment of unresectable breast cancer. ... Perjeta demonstrated "phenomenal" results at the European

BMS taps F-star Alpha for immuno-oncology drug

BMS taps F-star Alpha for immuno-oncology drug FS102 works differently to current HER2-targeted therapies such as Roche's Herceptin (trastuzumab) and Perjeta (pertuzumab), and is being developed specifically to meet the problem of resistance to those drugs.

Strong sales in breast cancer lift Roche revenues

Strong sales in breast cancer lift Roche revenues New products Perjeta and Kadcyla lead growth. Rocketing sales of Roche's new breast cancer drugs Perjeta and Kadcyla suggest they will cushion any impact from biosimilar competition to Herceptin, which ... Last month, Roche reported new clinical data

Janssen, AZ and Roche at ESMO

Janssen, AZ and Roche at ESMO In addition to using ESMO to post data that suggests Perjeta (pertuzumab) should be the new standard in breast cancer, the company also presented positive results for its investigational MEK inhibitor

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...

Infographics